Clinical Trials Directory

Trials / Completed

CompletedNCT00220922

A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.

An Open-Label, Randomized, Single Cross-Over Study of Isopropyl Alcohol Wipes Versus No Injection Site Preparation on Local Injection Site Reactions Among Persons With Multiple Sclerosis Who Perform Daily Injections of Copaxone®

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Teva Neuroscience, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is designed to compare injection site reactions with or without the use of alcohol wipes prior to performing the patients' daily Copaxone® injection.

Conditions

Interventions

TypeNameDescription
PROCEDUREAlcohol Wipes vs. No Alcohol Wipes

Timeline

Start date
2004-08-01
Primary completion
2005-10-01
Completion
2006-02-01
First posted
2005-09-22
Last updated
2011-04-08

Source: ClinicalTrials.gov record NCT00220922. Inclusion in this directory is not an endorsement.